Code Biotherapeutics

View the org chart displaying its 19 main executives

Most searched biographies at Code Biotherapeutics

• Brian McVeigh, Chief Executive Officer and Chairman of the Board
• Jason Baranski, Director
• Diana Bernstein, Director

Create your alert
to follow the executive moves at Code Biotherapeutics.

Code Biotherapeutics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Code Biotherapeutics

Social media about Code Biotherapeutics

• Code Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Code Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Joseph Truitt

Call Code Biotherapeutics at +1 312...

View the org chart

Register to receive your alert

Report an error